Please see below for a list of search results.
The McCracken review looked at how the HTA and HFEA could be more efficient. The HTA has fully incorporated its recommendations.
The HTA has a responsibility to make its information available in accordance with the FOI Act.
In order to increase the accessibility of this site, we have provided a number of Access keys. These are keyboard shortcuts providing an alternative form of navigation.
The Human Tissue Authority (HTA) is an Executive Non-Departmental Public Body (ENDPB) sponsored by the Department of Health and Social Care and as such has a framework agreement.
The Human Tissue Authority (HTA) is the national independent regulator for organisations that remove, store and use tissue for research, medical treatment, post-mortem examination, teaching and display in public. We also give approval for organ and bone marrow donations from living people.
The Human Tissue Authority is committed to promoting equality and diversity, both as an employer and in the carrying out of its public functions to monitor and promote good practice in the sectors that it regulates.
Accuracy of informationPlease note the following: Every effort has been made to ensure that the information provided on this website is accurate, but accuracy cannot be guaranteed and the information provided does not constitute legal or other professional advice.
According to the 2013 House of Lords report on Regenerative Medicine, the term ‘regenerative medicine’ refers to methods to replace or regenerate human cells, tissues or organs in order to restore or establish normal function.